Product Information
FT IBUPROFEN PM 200-38 MG CPLT is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1313 per EA under NDC 70677113101. Its NADAC has been published 107 times since Aug 7, 2024.
FDA first approved this application on Dec 22, 2008.
Strength
38; 200 mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677113101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIPHENHYDRAMINE CITRATE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA079113FDA Approved
12/22/2008
On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for FT IBUPROFEN PM 200-38 MG CPLT has been published 107 times since Aug 7, 2024, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1313 per EA |
|---|---|
| All-time high | $0.1313 (Aug 19, 2026) |
| All-time low | $0.1220 (Nov 20, 2024) |
| 52-week high | $0.1313 |
| 52-week low | $0.1249 |
| Median price | $0.1257 |
| Average price | $0.1257 |
| Largest weekly change | +3.3% (Oct 23, 2024) |
| Weeks tracked | 107 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FT IBUPROFEN PM 200-38 MG CPLT?
The current National Average Drug Acquisition Cost (NADAC) for FT IBUPROFEN PM 200-38 MG CPLT, manufactured by Strategic Sourcing Services LLC, is $0.1313 per EA (NDC 70677113101), effective Aug 19, 2026.
How has the price of FT IBUPROFEN PM 200-38 MG CPLT changed over time?
Over the history we have for it, the NADAC for FT IBUPROFEN PM 200-38 MG CPLT has risen 5.1%. It has been tracked across 107 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for FT IBUPROFEN PM 200-38 MG CPLT?
Since Aug 7, 2024, the NADAC for FT IBUPROFEN PM 200-38 MG CPLT has ranged from a low of $0.1220 (Nov 20, 2024) to a high of $0.1313 (Aug 19, 2026), with a median of $0.1257 per EA.
Are there cheaper alternatives to FT IBUPROFEN PM 200-38 MG CPLT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN PM CAPLET, is $0.1250 per EA — about 5% below FT IBUPROFEN PM 200-38 MG CPLT.
Who manufactures FT IBUPROFEN PM 200-38 MG CPLT?
FT IBUPROFEN PM 200-38 MG CPLT (NDC 70677113101) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.